Drug Profile
Research programme: cognitive enhancement drugs - Ophidion
Latest Information Update: 28 Aug 2018
Price :
$50
*
At a glance
- Originator Ophidion
- Class Peptides; Small molecules
- Mechanism of Action Nicotinic receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 28 Aug 2018 No recent reports of development identified for research development in Cognition-disorders in USA
- 04 Aug 2016 Early research is ongoing in USA